| Prostate cancer relevant antigens and enzymes for targeted drug delivery A Barve, W Jin, K Cheng Journal of Controlled Release 187, 118-132, 2014 | 117 | 2014 |
| Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy H Liu, Z Zhao, L Zhang, Y Li, A Jain, A Barve, W Jin, Y Liu, J Fetse, ... Journal for immunotherapy of cancer 7, 1-14, 2019 | 90 | 2019 |
| Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer CY Xie, YP Xu, W Jin, LG Lou Anti-cancer drugs 23 (7), 698-705, 2012 | 82 | 2012 |
| Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery A Jain, A Barve, Z Zhao, W Jin, K Cheng Molecular pharmaceutics 14 (5), 1517-1527, 2017 | 81 | 2017 |
| Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells Z Zhao, Y Li, A Jain, Z Chen, H Liu, W Jin, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 14 (1), 51-61, 2018 | 53 | 2018 |
| Discovery of PSMA-specific peptide ligands for targeted drug delivery W Jin, B Qin, Z Chen, H Liu, A Barve, K Cheng International Journal of Pharmaceutics 513 (1-2), 138-147, 2016 | 46 | 2016 |
| Development of cholesteryl peptide micelles for siRNA delivery B Qin, Z Chen, W Jin, K Cheng Journal of Controlled Release 172 (1), 159-168, 2013 | 42 | 2013 |
| Discovery of Peptide ligands for hepatic stellate cells using phage display Z Chen, W Jin, H Liu, Z Zhao, K Cheng Molecular pharmaceutics 12 (6), 2180-2188, 2015 | 40 | 2015 |
| An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer A Barve, A Jain, H Liu, W Jin, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2373-2381, 2016 | 34 | 2016 |
| Development of streptavidin-based nanocomplex for siRNA delivery RS Shukla, W Tai, R Mahato, W Jin, K Cheng Molecular pharmaceutics 10 (12), 4534-4545, 2013 | 29 | 2013 |
| 7-Cycloalkylcamptothecin derivatives: Preparation and biological evaluation M Li, W Jin, C Jiang, C Zheng, W Tang, T You, L Lou Bioorganic & medicinal chemistry letters 19 (15), 4107-4109, 2009 | 22 | 2009 |
| Silencing of α-complex protein-2 reverses alcohol-and cytokine-induced fibrogenesis in hepatic stellate cells H Liu, Z Chen, W Jin, A Barve, YJY Wan, K Cheng Liver research 1 (1), 70-79, 2017 | 19 | 2017 |
| The covalent SNAP tag for protein display quantification and low-pH protein engineering W Jin, B Madan, BK Mussman, AT Hailemariam, AS Fahad, JR Wolfe, ... Journal of biotechnology 320, 50-56, 2020 | 4 | 2020 |
| Noncovalent Attachment of Chemical Moieties to siRNAs Using Peptide Nucleic Acid as a Complementary Linker W Jin, A Jain, H Liu, Z Zhao, K Cheng ACS applied bio materials 1 (3), 643-651, 2018 | 4 | 2018 |
| Psma-specific ligands in prostate cancer diagnosis and therapy KC Wei Jin, Ashutosh Barve European Medical Journal 2016 (4[1]), 62-69, 2016 | 3* | 2016 |
| Compositions including igg fc mutations and uses thereof B Dekosky, PD Kwong, W Jin, Y Do Kwon, B Zhang US Patent App. 17/638,139, 2022 | 1 | 2022 |
| Bioconjugation of siRNA for Site‐specific Delivery B Qin, W Jin, K Cheng Advanced Delivery and Therapeutic Applications of RNAi, 111-136, 2013 | 1 | 2013 |
| Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries A Huang, W Jin, AS Fahad, BK Mussman, GP Nicchia, B Madan, ... Antibodies 11 (2), 39, 2022 | | 2022 |
Zhen ZhaoHebei University of Technology, Tianjin, China在 hebut.edu.cn 的电子邮件经过验证
